Huge achievement to grow in a diminishing market and sit where it is. I always found the analysts sentencing the stock to go down because the birth rate was going down in China a bit simplistic given its reputation there . Marketing the A2 benefits for infants in China where many react to milk badly to seniors is a good move. Other companies have got into that sector globally so was inevitable.
Ann: 1H24 Results Presentation, page-38
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.91 |
Change
-0.010(0.20%) |
Mkt cap ! $3.554B | |||
| Open | High | Low | Value | Volume |
| $4.93 | $4.96 | $4.89 | $5.556M | 1.127M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 63209 | $4.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.92 | 20435 | 4 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |